arrow
S

S. Zúñiga

incliva biomedical research institute
H指数:12
被引数:1,015

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Autologous cell therapy with CD133+ bone marrow-derived stem cells for Asherman Syndrome: a phase 1/2 trial

自体CD133<sup>+</sup>骨髓来源干细胞疗法治疗阿什曼综合征:一项1/2期临床试验

2026-01-020
OAAI
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids

通过整合组学和患者源性类器官解码结直肠癌中的染色体不稳定性见解

2025-02-280
OA
Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction

用于药物敏感性预测的晚期结直肠癌患者衍生的类器官的蛋白质转录组学分析

2023-01-0629
OAAI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
2022-10-173
OA
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study
2021-09-0719
OAAI
Exome sequencing of ctDNA portrays the mutational landscape of patients with relapsing colon cancer and indicates new actionable targets
2021-09-011
OAAI
Characterizing diversity in the immune profile by a transcriptomic customized gene signature to potentially personalize treatment in advanced gastric cancer patients
2021-09-010
OAAI
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor
2020-09-010
OAAI
The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy
2020-09-010
OAAI
Sequencing paired tumor DNA and white blood cells (WBCs) increases sensitivity to track plasma circulating tumor DNA (ctDNA) for detecting minimal residual disease (MRD) in localized colon cancer (CC)
2020-09-010
OAAI
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer
2020-01-0125
OAAI
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

循环肿瘤DNA的靶向下一代测序用于追踪局部结肠癌的最小残留疾病

2019-11-01184
OAAI